These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29726078)

  • 1. Unrelated and related donor transplantation for beta-thalassemia major: A single-center experience from India.
    John MJ; Mathew A; Philip CC; Singh S; Tanuja T; Kakkar N
    Pediatr Transplant; 2018 Aug; 22(5):e13209. PubMed ID: 29726078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matched Family versus Alternative Donor Hematopoietic Stem Cell Transplantation for Patients with Thalassemia Major: Experience from a Tertiary Referral Center in South India.
    Swaminathan VV; Uppuluri R; Patel S; Ravichandran N; Ramanan KM; Vaidhyanathan L; Ramakrishnan B; Jayakumar I; Raj R
    Biol Blood Marrow Transplant; 2020 Jul; 26(7):1326-1331. PubMed ID: 32200123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term survival of beta thalassemia major patients treated with hematopoietic stem cell transplantation compared with survival with conventional treatment.
    Caocci G; Orofino MG; Vacca A; Piroddi A; Piras E; Addari MC; Caria R; Pilia MP; Origa R; Moi P; La Nasa G
    Am J Hematol; 2017 Dec; 92(12):1303-1310. PubMed ID: 28850704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic Stem Cell Transplantation in Congenital Hemoglobinopathies Using a Tailored Busulfan-Based Conditioning Regimen: Single-Center Experience.
    Zaidman I; Rowe JM; Khalil A; Ben-Arush M; Elhasid R
    Biol Blood Marrow Transplant; 2016 Jun; 22(6):1043-1048. PubMed ID: 27016193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second Hematopoietic Stem Cell Transplant for Thalassemia Major: Improved Clinical Outcomes with a Treosulfan-Based Conditioning Regimen.
    Korula A; Pn N; Devasia A; Lakshmi KM; Abraham A; Sindhuvi E; George B; Srivastava A; Mathews V
    Biol Blood Marrow Transplant; 2018 Jan; 24(1):103-108. PubMed ID: 29032269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic stem cell transplantation for children with β-thalassemia major: multicenter experience in China.
    Li XY; Sun X; Chen J; Qin MQ; Luan Z; Zhu YP; Fang JP
    World J Pediatr; 2018 Feb; 14(1):92-99. PubMed ID: 29511925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treosulfan-thiotepa-fludarabine-based conditioning regimen for allogeneic transplantation in patients with thalassemia major: a single-center experience from north India.
    Choudhary D; Sharma SK; Gupta N; Kharya G; Pavecha P; Handoo A; Setia R; Katewa S
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):492-5. PubMed ID: 23160007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogenic Hematopoietic Cell Transplantation in Thalassemia Major: A Single-center Retrospective Analysis From India.
    Choudhary D; Doval D; Sharma SK; Khandelwal V; Setia R; Handoo A
    J Pediatr Hematol Oncol; 2019 Jul; 41(5):e296-e301. PubMed ID: 30933028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.
    Bryant A; Mallick R; Huebsch L; Allan D; Atkins H; Anstee G; Sabloff M; Scrivens N; Maze D; Bredeson C; Kekre N
    Biol Blood Marrow Transplant; 2017 Dec; 23(12):2096-2101. PubMed ID: 28821454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic stem cell transplantation from non-sibling matched family donors for patients with thalassemia major in Jordan.
    Hussein AA; Al-Zaben A; Khattab E; Haroun A; Frangoul H
    Pediatr Transplant; 2016 Feb; 20(1):120-3. PubMed ID: 26493691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matched sibling versus matched unrelated allogeneic hematopoietic stem cell transplantation in children with severe acquired aplastic anemia: experience of the polish pediatric group for hematopoietic stem cell transplantation.
    Szpecht D; Gorczyńska E; Kałwak K; Owoc-Lempach J; Choma M; Styczyński J; Goździk J; Dłużniewska A; Wysocki M; Kowalczyk JR; Chybicka A; Pieczonka A; Wachowiak J
    Arch Immunol Ther Exp (Warsz); 2012 Jun; 60(3):225-33. PubMed ID: 22527354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors.
    Solomon SR; Sizemore CA; Sanacore M; Zhang X; Brown S; Holland HK; Morris LE; Bashey A
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1299-307. PubMed ID: 25797174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Allogeneic hematopoietic stem cell transplantation for beta-thalassemia major].
    Li CF; He YL; Zhang YM; Yang M; Wu XD; Bai J
    Zhonghua Xue Ye Xue Za Zhi; 2003 Apr; 24(4):174-6. PubMed ID: 12864945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretransplant myeloid and immune suppression, reduced toxicity conditioning with posttransplant cyclophosphamide: Initial outcomes of novel approach for matched unrelated donor hematopoietic stem cell transplant for hemoglobinopathies.
    Kharya G; Bakane AN; Rauthan AM
    Pediatr Blood Cancer; 2021 Apr; 68(4):e28909. PubMed ID: 33470527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel conditioning regimen improves outcomes in β-thalassemia major patients using unrelated donor peripheral blood stem cell transplantation.
    Li C; Wu X; Feng X; He Y; Liu H; Pei F; Liao J; He L; Shi L; Li N; Liu Q; Liu S; Chen G; Su Q; Ren Y; Wang Y; Tan W
    Blood; 2012 Nov; 120(19):3875-81. PubMed ID: 22968457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter Outcome of Hematopoietic Stem Cell Transplantation for Primary Immune Deficiency Disorders in India.
    Raj R; Aboobacker FN; Yadav SP; Uppuluri R; Bhat S; Choudhry D; Dua V; Kharya G; Rastogi N; Sachdev M; Khandelwal V; Swaminathan V; Bakane A; Ramakrishnan B; George B
    Front Immunol; 2020; 11():606930. PubMed ID: 33488609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalassemia-free and graft-versus-host-free survival: outcomes of hematopoietic stem cell transplantation for thalassemia major, Turkish experience.
    Yesilipek MA; Uygun V; Kupesiz A; Karasu G; Ozturk G; Ertem M; Şaşmaz İ; Daloğlu H; Güler E; Hazar V; Fisgin T; Sezgin G; Kansoy S; Kuşkonmaz B; Akıncı B; Özbek N; İnce EÜ; Öztürkmen S; Küpesiz FT; Yalçın K; Anak S; Bozkurt C; Karakükçü M; Küpeli S; Albayrak D; Öniz H; Aksoylar S; Okur FV; Albayrak C; Yenigürbüz FD; Bozkaya İO; İleri T; Gürsel O; Karagün BŞ; Kintrup GT; Çelen S; Elli M; Aksoy BA; Yılmaz E; Tanyeli A; Akyol ŞT; Siviş ZÖ; Özek G; Uçkan D; Kartal İ; Atay D; Akyay A; Bilir ÖA; Çakmaklı HF; Kürekçi E; Malbora B; Akbayram S; Demir HA; Kılıç SÇ; Güneş AM; Zengin E; Özmen S; Antmen AB
    Bone Marrow Transplant; 2022 May; 57(5):760-767. PubMed ID: 35210564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Multicenter Retrospective Analysis Stressing the Importance of Long-Term Follow-Up after Hematopoietic Cell Transplantation for β-Thalassemia.
    Chaudhury S; Ayas M; Rosen C; Ma M; Viqaruddin M; Parikh S; Kharbanda S; Chiang KY; Haight A; Bhatia M; Guilcher G; Thompson A; Shenoy S
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1695-1700. PubMed ID: 28627425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor outcome with nonmyeloablative conditioning regimen before cord blood transplantation for patients with high-risk acute myeloid leukemia compared with matched related or unrelated donor transplantation.
    Devillier R; Harbi S; Fürst S; Crocchiolo R; El-Cheikh J; Castagna L; Etienne A; Calmels B; Lemarie C; Prebet T; Granata A; Charbonnier A; Rey J; Chabannon C; Faucher C; Vey N; Blaise D
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1560-5. PubMed ID: 24933658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-Center Experience of Unrelated and Haploidentical Stem Cell Transplantation with TCRαβ and CD19 Depletion in Children with Primary Immunodeficiency Syndromes.
    Balashov D; Shcherbina A; Maschan M; Trakhtman P; Skvortsova Y; Shelikhova L; Laberko A; Livshits A; Novichkova G; Maschan A
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1955-62. PubMed ID: 26187864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.